BLISSGVSPharmaceuticals
Bliss GVS Pharma Ltd — Balance Sheet
₹215.59
-3.69%
Bliss GVS Pharma Ltd Balance Sheet (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Ordinary Shares Number | 10.54 Cr | 10.47 Cr | 10.42 Cr | 10.37 Cr | — |
| Share Issued | 10.54 Cr | 10.47 Cr | 10.42 Cr | 10.37 Cr | — |
| Net Debt | 47.18 Cr | 64.67 Cr | 73.11 Cr | 83.04 Cr | — |
| Total Debt | 88.10 Cr | 99.84 Cr | 101.90 Cr | 109.39 Cr | — |
| Tangible Book Value | 1.04K Cr | 959.38 Cr | 875.96 Cr | 810.61 Cr | — |
| Invested Capital | 1.12K Cr | 1.05K Cr | 981.96 Cr | 923.66 Cr | — |
| Working Capital | 654.79 Cr | 653.47 Cr | 504.11 Cr | 543.77 Cr | — |
| Net Tangible Assets | 1.04K Cr | 959.38 Cr | 875.96 Cr | 810.61 Cr | — |
| Capital Lease Obligations | 17.13 Cr | 12.03 Cr | 3.83 Cr | 4.43 Cr | — |
| Common Stock Equity | 1.05K Cr | 967.19 Cr | 883.90 Cr | 818.70 Cr | — |
| Total Capitalization | 1.07K Cr | 1.00K Cr | 924.59 Cr | 841.92 Cr | — |
| Total Equity Gross Minority Interest | 1.09K Cr | 1.00K Cr | 917.42 Cr | 846.46 Cr | — |
| Minority Interest | 41.47 Cr | 35.79 Cr | 33.53 Cr | 27.76 Cr | — |
| Stockholders Equity | 1.05K Cr | 967.19 Cr | 883.90 Cr | 818.70 Cr | — |
| Other Equity Interest | 6.29 Cr | 7.72 Cr | 8.89 Cr | 9.94 Cr | — |
| Retained Earnings | 966.61 Cr | 886.99 Cr | 814.92 Cr | 748.72 Cr | — |
| Additional Paid In Capital | 40.42 Cr | 33.16 Cr | 26.99 Cr | 21.28 Cr | — |
| Capital Stock | 10.54 Cr | 10.47 Cr | 10.42 Cr | 10.37 Cr | — |
| Common Stock | 10.54 Cr | 10.47 Cr | 10.42 Cr | 10.37 Cr | — |
| Total Liabilities Net Minority Interest | 208.99 Cr | 208.61 Cr | 239.43 Cr | 262.28 Cr | — |
| Total Non Current Liabilities Net Minority Interest | 37.28 Cr | 51.20 Cr | 46.17 Cr | 29.20 Cr | — |
| Other Non Current Liabilities | 0.05 Cr | 0.06 Cr | 0.07 Cr | 0.09 Cr | — |
| Non Current Pension And Other Postretirement Benefit Plans | 4.36 Cr | 2.67 Cr | 2.69 Cr | 1.07 Cr | — |
| Non Current Deferred Revenue | 0.05 Cr | 0.06 Cr | 0.07 Cr | 0.09 Cr | — |
| Non Current Deferred Taxes Liabilities | 0.30 Cr | 3.59 Cr | 0.00 | 1.32 Cr | — |
| Long Term Debt And Capital Lease Obligation | 32.56 Cr | 44.87 Cr | 43.41 Cr | 26.71 Cr | — |
| Long Term Capital Lease Obligation | 12.72 Cr | 9.28 Cr | 2.72 Cr | 3.49 Cr | — |
| Long Term Debt | 19.85 Cr | 35.59 Cr | 40.69 Cr | 23.22 Cr | — |
| Long Term Provisions | 4.36 Cr | 2.54 Cr | 2.69 Cr | 1.07 Cr | — |
| Current Liabilities | 171.72 Cr | 157.41 Cr | 193.26 Cr | 233.09 Cr | — |
| Other Current Liabilities | 2.64 Cr | 0.65 Cr | 4.08 Cr | 0.09 Cr | — |
| Current Debt And Capital Lease Obligation | 55.54 Cr | 54.97 Cr | 58.49 Cr | 82.68 Cr | — |
| Current Capital Lease Obligation | 4.41 Cr | 2.75 Cr | 1.11 Cr | 0.94 Cr | — |
| Current Debt | 51.13 Cr | 52.21 Cr | 57.38 Cr | 81.73 Cr | — |
| Pensionand Other Post Retirement Benefit Plans Current | 0.64 Cr | 0.00 | — | 0.04 Cr | 0.11 Cr |
| Current Provisions | 0.64 Cr | — | 3.34 Cr | 5.28 Cr | 8.66 Cr |
| Payables | 108.29 Cr | 94.85 Cr | 127.21 Cr | 136.02 Cr | — |
| Other Payable | 32.54 Cr | 31.33 Cr | 37.26 Cr | 35.70 Cr | — |
| Dividends Payable | 0.55 Cr | 0.70 Cr | 0.83 Cr | 1.02 Cr | — |
| Total Tax Payable | 3.77 Cr | 1.87 Cr | 2.73 Cr | 6.69 Cr | — |
| Accounts Payable | 71.42 Cr | 60.97 Cr | 86.39 Cr | 92.61 Cr | — |
| Total Assets | 1.30K Cr | 1.21K Cr | 1.16K Cr | 1.11K Cr | — |
| Total Non Current Assets | 474.33 Cr | 400.72 Cr | 459.49 Cr | 331.89 Cr | — |
| Other Non Current Assets | 12.39 Cr | 12.66 Cr | 16.06 Cr | 23.32 Cr | — |
| Non Current Prepaid Assets | 4.96 Cr | 3.80 Cr | 1.93 Cr | 22.50 Cr | — |
| Non Current Deferred Taxes Assets | 0.00 | 0.00 | 3.33 Cr | 0.00 | — |
| Investmentin Financial Assets | 31.07 Cr | 8.02 Cr | 56.86 Cr | 5.78 Cr | — |
| Available For Sale Securities | 26.68 Cr | 4.41 Cr | 54.03 Cr | 3.40 Cr | — |
| Financial Assets Designatedas Fair Value Through Profitor Loss Total | 4.38 Cr | 3.61 Cr | 2.83 Cr | 2.38 Cr | — |
| Investment Properties | 0.68 Cr | 0.68 Cr | 0.69 Cr | 0.69 Cr | — |
| Goodwill And Other Intangible Assets | 7.94 Cr | 7.82 Cr | 7.94 Cr | 8.09 Cr | — |
| Other Intangible Assets | 0.23 Cr | 0.11 Cr | 0.23 Cr | 0.38 Cr | — |
| Goodwill | 7.71 Cr | 7.71 Cr | 7.71 Cr | 7.71 Cr | — |
| Net PPE | 429.68 Cr | 380.40 Cr | 388.74 Cr | 294.82 Cr | — |
| Accumulated Depreciation | -124.39 Cr | -96.79 Cr | -79.18 Cr | -61.30 Cr | — |
| Gross PPE | 554.07 Cr | 477.18 Cr | 467.92 Cr | 356.13 Cr | — |
| Construction In Progress | 32.67 Cr | 18.85 Cr | 18.63 Cr | 22.15 Cr | — |
| Other Properties | 397.01 Cr | 361.55 Cr | 370.11 Cr | 272.67 Cr | — |
| Machinery Furniture Equipment | 315.61 Cr | 261.62 Cr | 258.04 Cr | 180.87 Cr | — |
| Buildings And Improvements | 163.55 Cr | 155.73 Cr | 149.27 Cr | 111.10 Cr | — |
| Land And Improvements | 42.24 Cr | 40.99 Cr | 41.98 Cr | 42.01 Cr | — |
| Properties | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Current Assets | 826.51 Cr | 810.87 Cr | 697.37 Cr | 776.86 Cr | — |
| Other Current Assets | 29.87 Cr | 58.73 Cr | 95.26 Cr | 70.52 Cr | — |
| Assets Held For Sale Current | 7.17 Cr | 0.00 | — | — | — |
| Restricted Cash | 71.96 Cr | 75.81 Cr | 39.59 Cr | 42.58 Cr | — |
| Prepaid Assets | 29.87 Cr | 57.98 Cr | 95.26 Cr | 70.50 Cr | — |
| Inventory | 125.73 Cr | 118.45 Cr | 103.06 Cr | 123.94 Cr | — |
| Other Inventories | 15.18 Cr | 16.50 Cr | 14.96 Cr | 14.80 Cr | — |
| Finished Goods | 49.00 Cr | 40.29 Cr | 33.80 Cr | 56.96 Cr | — |
| Work In Process | 5.70 Cr | 6.30 Cr | 4.44 Cr | 8.23 Cr | — |
| Raw Materials | 55.85 Cr | 55.36 Cr | 49.86 Cr | 43.95 Cr | — |
| Other Receivables | 8.92 Cr | 10.56 Cr | 4.26 Cr | 10.99 Cr | — |
| Taxes Receivable | 3.12 Cr | 2.91 Cr | 1.62 Cr | 1.08 Cr | — |
| Accounts Receivable | 438.36 Cr | 404.35 Cr | 385.17 Cr | 392.75 Cr | — |
| Allowance For Doubtful Accounts Receivable | -48.57 Cr | -36.21 Cr | -35.40 Cr | -14.67 Cr | — |
| Gross Accounts Receivable | 486.93 Cr | 440.56 Cr | 420.56 Cr | 407.42 Cr | — |
| Cash Cash Equivalents And Short Term Investments | 141.37 Cr | 140.82 Cr | 68.41 Cr | 135.01 Cr | — |
| Other Short Term Investments | 117.57 Cr | 117.68 Cr | 43.46 Cr | 113.10 Cr | — |
| Cash And Cash Equivalents | 23.79 Cr | 23.14 Cr | 24.96 Cr | 21.92 Cr | — |
| Cash Equivalents | 13.26 Cr | 5.62 Cr | 2.47 Cr | 8.36 Cr | — |
| Cash Financial | 10.53 Cr | 17.52 Cr | 22.49 Cr | 13.56 Cr | — |
| Other Investments | — | — | — | 0.23 Cr | — |
| Held To Maturity Securities | — | — | — | 2.15 Cr | — |
| Long Term Equity Investment | — | — | — | — | 0.00 |
| Investmentsin Subsidiariesat Cost | — | — | — | — | 0.00 |
| Inventories Adjustments Allowances | — | — | — | — | 0.00 |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Bliss GVS Pharma Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.